194 related articles for article (PubMed ID: 10739169)
1. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer.
Watanabe J; Shimada T; Gillam EM; Ikuta T; Suemasu K; Higashi Y; Gotoh O; Kawajiri K
Pharmacogenetics; 2000 Feb; 10(1):25-33. PubMed ID: 10739169
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer risk in relation to the CYP2C9*1/CYP2C9*2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California.
London SJ; Daly AK; Leathart JB; Navidi WC; Idle JR
Pharmacogenetics; 1996 Dec; 6(6):527-33. PubMed ID: 9014202
[TBL] [Abstract][Full Text] [Related]
3. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
[TBL] [Abstract][Full Text] [Related]
4. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer.
Bailey LR; Roodi N; Dupont WD; Parl FF
Cancer Res; 1998 Nov; 58(22):5038-41. PubMed ID: 9823305
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity.
Hanna IH; Dawling S; Roodi N; Guengerich FP; Parl FF
Cancer Res; 2000 Jul; 60(13):3440-4. PubMed ID: 10910054
[TBL] [Abstract][Full Text] [Related]
6. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
[TBL] [Abstract][Full Text] [Related]
7. Catalytic properties of polymorphic human cytochrome P450 1B1 variants.
Shimada T; Watanabe J; Kawajiri K; Sutter TR; Guengerich FP; Gillam EM; Inoue K
Carcinogenesis; 1999 Aug; 20(8):1607-13. PubMed ID: 10426814
[TBL] [Abstract][Full Text] [Related]
8. Human CYP1A1 (cytochrome P(1)450) gene: lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population.
Tefre T; Ryberg D; Haugen A; Nebert DW; Skaug V; Brøgger A; Børresen AL
Pharmacogenetics; 1991 Oct; 1(1):20-5. PubMed ID: 1726950
[TBL] [Abstract][Full Text] [Related]
9. NADPH- and hydroperoxide-supported 17beta-estradiol hydroxylation catalyzed by a variant form (432L, 453S) of human cytochrome P450 1B1.
Spink DC; Spink BC; Zhuo X; Hussain MM; Gierthy JF; Ding X
J Steroid Biochem Mol Biol; 2000 Sep; 74(1-2):11-8. PubMed ID: 11074351
[TBL] [Abstract][Full Text] [Related]
10. Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk.
Gsur A; Zidek T; Schnattinger K; Feik E; Haidinger G; Hollaus P; Mohn-Staudner A; Armbruster C; Madersbacher S; Schatzl G; Trieb K; Vutuc C; Micksche M
Br J Cancer; 2003 Aug; 89(4):702-6. PubMed ID: 12915882
[TBL] [Abstract][Full Text] [Related]
11. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types.
Alexandrie AK; Sundberg MI; Seidegård J; Tornling G; Rannug A
Carcinogenesis; 1994 Sep; 15(9):1785-90. PubMed ID: 7923570
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in P450 CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol.
Li DN; Seidel A; Pritchard MP; Wolf CR; Friedberg T
Pharmacogenetics; 2000 Jun; 10(4):343-53. PubMed ID: 10862525
[TBL] [Abstract][Full Text] [Related]
13. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population.
Kihara M; Kihara M; Noda K
Carcinogenesis; 1995 Oct; 16(10):2331-6. PubMed ID: 7586131
[TBL] [Abstract][Full Text] [Related]
14. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
Saintot M; Malaveille C; Hautefeuille A; Gerber M
Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
[TBL] [Abstract][Full Text] [Related]
15. Specificity of 17beta-oestradiol and benzo[a]pyrene oxidation by polymorphic human cytochrome P4501B1 variants substituted at residues 48, 119 and 432.
Shimada T; Watanabe J; Inoue K; Guengerich FP; Gillam EM
Xenobiotica; 2001 Mar; 31(3):163-76. PubMed ID: 11465393
[TBL] [Abstract][Full Text] [Related]
16. Interaction between genetic polymorphism of cytochrome P450-1B1 and environmental pollutants in breast cancer risk.
Saintot M; Malaveille C; Hautefeuille A; Gerber M
Eur J Cancer Prev; 2004 Feb; 13(1):83-6. PubMed ID: 15075793
[TBL] [Abstract][Full Text] [Related]
17. Association of functionally important polymorphisms in cytochrome P4501B1 with lung cancer.
Shah PP; Singh AP; Singh M; Mathur N; Mishra BN; Pant MC; Parmar D
Mutat Res; 2008 Aug; 643(1-2):4-10. PubMed ID: 18573508
[TBL] [Abstract][Full Text] [Related]
18. Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations.
Inoue K; Asao T; Shimada T
Xenobiotica; 2000 Mar; 30(3):285-95. PubMed ID: 10752643
[TBL] [Abstract][Full Text] [Related]
19. No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects.
Yao L; Fang F; Wu Q; Zhong Y; Yu L
Breast Cancer Res Treat; 2010 Jul; 122(1):237-42. PubMed ID: 20033481
[TBL] [Abstract][Full Text] [Related]
20. O6-alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer.
Chae MH; Jang JS; Kang HG; Park JH; Park JM; Lee WK; Kam S; Lee EB; Son JW; Park JY
Mol Carcinog; 2006 Apr; 45(4):239-49. PubMed ID: 16385589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
